Quaker Bioventures News
Most Popular Quaker Bioventures Story
Tobira garners $31M to advance HIV drugs
Up-start biotech Tobira Therapeutics, which is developing HIV/AIDS drugs, has raised $31 million in its first round of venture capital. Domain Associates and Frazier Healthcare Ventures led the round... Read more...
Latest Headlines
- March 31, 2008
- November 1, 2007
- August 15, 2007
- August 2, 2007
- September 12, 2006
- August 9, 2006
- July 31, 2006
- June 28, 2006
- June 26, 2006
- April 19, 2006
- April 10, 2006
- February 22, 2006
- February 20, 2006
- September 29, 2005
- September 7, 2005
- July 13, 2005
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
